CorMedix Inc — Cash Flow (NASDAQ:CRMD) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities -21.97 M-21.16 M-24.36 M-38.41 M-50.61 M 74.97 M Cash from investing activities 7.43 M-9.13 M-3.71 M-17.06 M21.23 M -312.03 M Cash from financing activities 40.1 M41.76 M17.9 M55.92 M26.32 M 251.15 M Free cash flow -22.08 M-22.58 M-24.58 M-38.74 M-50.73 M 74.42 M

Новости

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?

Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?

CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?

CorMedix Inc. (CRMD) Analyst/Investor Day Transcript

CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11

Citizens подтверждает рейтинг Market Outperform для акций CorMedix

CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside

Акции CorMedix растут после объявления о выкупе акций на $75 млн

CorMedix stock rises after announcing $75 million share buyback plan

CorMedix объявляет о программе обратного выкупа акций на $75 млн

CorMedix announces $75 million share repurchase program